Navigation Links
UCB and Amgen Initiate Sclerostin Antibody Phase 3 Program in Patients With Postmenopausal Osteoporosis
Date:4/3/2012

BRUSSELS and THOUSAND OAKS, Calif., April 4, 2012 /PRNewswire/ -- UCB (Euronext Brussels: UCB) and Amgen (NASDAQ: AMGN) announced today the start of their sclerostin antibody (CDP7851/AMG 785) Phase 3 clinical trial program for the treatment of postmenopausal osteoporosis.

"We look forward to working with UCB on the CDP7851/AMG 785 Phase 3 program," said Sean E. Harper, M.D., executive vice president of Research and Development at Amgen. "Despite available osteoporosis therapies, there remains a significant need for additional treatment options that form new bone in women diagnosed with postmenopausal osteoporosis."

"Our sclerostin antibody project with Amgen is one of the most exciting pipeline programs in UCB's portfolio.  Data collected so far indicate the potential for a change of treatment paradigms in postmenopausal osteoporosis," said Prof. Dr. med. Iris Loew-Friedrich, Chief Medical Officer of UCB and Executive Vice-President Global Projects and Development. "We are delighted about the start of the Phase 3 program. The progress made to date encourages and motivates us as we work toward providing a new treatment option for women living with postmenopausal osteoporosis."

The Phase 3 program includes a multicenter, international, randomized, double-blind, placebo-controlled, parallel-group, two-year study in more than 5,000 postmenopausal women with osteoporosis.  The primary endpoint will evaluate the incidence of new vertebral fractures at 12 months. Initial results from the Phase 3 program are expected by the end of 2015.

CDP7851/AMG 785 is a humanized monoclonal antibody that binds to and inhibits sclerostin, a protein secreted by bone cells that inhibits bone formation. By binding to and blocking sclerostin, CDP7851/AMG 785 is designed to increase the amount of bone in the skeleton. With more than 75 million people worldwide suffe
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Arthritis Foundation Announces Amgen and Wyeth to Be Presenting Sponsor of the 2008 Arthritis Walk (R)
2. Medarex to Receive Milestone Payment from Amgen
3. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
4. Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer
5. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
6. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
7. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
10. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
11. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... , Aug. 30, 2014  Boston Scientific ... NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) clinical ... trial investigating vagus nerve stimulation (VNS) for the ... Ph.D., Professor of Therapeutics and Cardiology and Director ... National de la Sante et de la Recherche ...
(Date:8/30/2014)...   Royal Philips  (NYSE: PHG, AEX: PHIA) today ... ultrasound system designed to enable global hospitals and health ... and cost pressures. Making its debut at the  European ... Barcelona this week, Affiniti provides innovative technology ... resources deliver high quality patient care. ...
(Date:8/29/2014)... Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research Report ... 2009-2019 is a professional and in-depth market survey ... industry . The report firstly reviews the basic ... application and manufacturing technology. The report then explores ... Scanner listing their product specification, capacity, Production value, ...
Breaking Medicine Technology:Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 2Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 3Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial 4Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 2Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 3Philips Debuts New Affiniti Ultrasound System at the European Society of Cardiology Congress 2014 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5
... Osteotech, Inc. (Nasdaq: OSTE ), a leader in the ... the Company,s first quarter ended March 31, 2010 financial ... May 10, 2010 .  The management team of Osteotech will host ... , at 9:00 a.m. (EDT) to discuss the Company,s ...
... Doctora Aliza, editor in chief of VidaySalud.com and expert health commentator for the ... Latino Legislative Caucus during a special Assembly floor session at the California Capitol ... , (Photo: ... "Doctor Aliza ...
Cached Medicine Technology:Osteotech Announces First Quarter 2010 Financial Results Release and Conference Call 2Latino Spirit Award For VidaySalud.com's Doctora Aliza 2
(Date:8/31/2014)... Obese youths have a nearly six fold risk ... ,22 000 young people from the PEP Family ... Professor Peter Schwandt from Germany. , Professor Schwandt ... children and adolescents is continuing to rise in ... considered a driving force for cardiovascular disease, we ...
(Date:8/31/2014)... California (PRWEB) August 31, 2014 ... environmentally harmful disc brake dust at the source ... , Problem: Millions of vehicles globally emit brake ... ingredients in the friction materials (disc brake pads) ... the nations’ water systems. For example, copper impairs ...
(Date:8/31/2014)... 2014 Priya Khan, Director of ... concern over misinformation about weight-loss supplements saying, “Consumers ... often, misleading information being propagated by unscrupulous companies ... are weighing in on the subject. , NutriGold’s ... and especially weight-loss products and to provide them ...
(Date:8/31/2014)... (PRWEB) August 31, 2014 To make ... supplement brand they can trust, NutriGold is shipping complimentary ... A form has been set up to make taking ... , According to Priya Khan, Director of Research ... customers purchase one of our products, they are entrusting ...
(Date:8/31/2014)... 2014 “Prohibition is our history,” ... our future: the present ~ that’s political.” , ... , new on the Bryan William Brickner Blog, ... system (CS) modulation and homeostasis - including one ... use. The Publius CS update includes: heteromerization ...
Breaking Medicine News(10 mins):Health News:Obese youths have a nearly 6 fold risk of hypertension 2Health News:CBPModular Technology with Global Patent Coverage Solves Vehicle Wheel Brake Dust Problem 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 2Health News:New Reasons to Verify Label Claims on Weight-loss Products Before Buying 3Health News:Whole-food Supplement Samples Now Offered by NutriGold 2Health News:Whole-food Supplement Samples Now Offered by NutriGold 3Health News:Homeostasis: Publius’ Alcohol Political Cannabinoid Science ~ New on the Bryan William Brickner Blog 2
... of Michigan evolutionary biologist Jianzhi "George" Zhang, has uncovered ... a sex determiner in honey bees. These novel inputs ... methods to breed honeybees, who are effective pollinators of ... findings of Zhang and collaborators are published in a ...
... to pain.In the study conducted on rats, the development// ... expression of that particular gene after a nerve injury ... of new painkillers. ,"Studies in volunteers showed ... variant that protects them from pain somewhat, and three ...
... disease is to be resumed and researchers from Southampton University ... ,The progress of the disease was supposed to be reversed ... the disease. But during the second phase of the trial, ... the study was brought to a halt for safety ...
... plastic and reconstructive surgeon has been given the go-ahead ... the Royal Free Hospital, London to select four patients ... College of Surgeons has called for caution with leading ... surgery promises to transform the lives of hundreds of ...
... implanted in 65,000 dogs in Shanghai to improve canine management ... at curbing// rabies in provinces of Yunnan and Shandong drew ... ID number. To access information about the dog - photo, ... have to access the ID number. ,Chip developer ...
... Gleneagles Hospitals has asked the West Bengal government for 10 ... here for setting up// a Rs.1.5 billion institute. ... research in the medical field, said V. Satyanarayana Reddy, CEO, ... the government to identify and hand over a site for ...
Cached Medicine News:Health News:Breeding success by delving into the honey bee sex gene 2Health News:Breeding success by delving into the honey bee sex gene 3Health News:Gene determines pain threshold... 2Health News:Alzheimer's Vaccine- A Realistic Prospect 2Health News:Green Signal given to Full-Face Transplants 2Health News:Green Signal given to Full-Face Transplants 3
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Infusion Cannula, 6.0mm....
Subretinal Aspiration Cannula, Curved; 20g (0.90) x 1" (25mm); Tip Extension: 6.5mm, 27g (0.40); Angled at 60°, 2.5mm from Tip....
Subretinal Fluid Cannula, Straight; 20g (0.90) x 1-1/2" (38mm); 12mm Flexible Tubing Extends 6mm Beyond Tip....
Medicine Products: